Compare WEAV & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEAV | BVS |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 600.1M | 508.4M |
| IPO Year | 2021 | 2021 |
| Metric | WEAV | BVS |
|---|---|---|
| Price | $6.32 | $7.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $12.20 | ★ $13.33 |
| AVG Volume (30 Days) | ★ 1.5M | 396.3K |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.15 |
| Revenue | $229,790,000.00 | ★ $563,829,000.00 |
| Revenue This Year | $19.19 | N/A |
| Revenue Next Year | $15.09 | $7.22 |
| P/E Ratio | ★ N/A | $49.49 |
| Revenue Growth | ★ 17.34 | 1.58 |
| 52 Week Low | $5.64 | $5.81 |
| 52 Week High | $17.63 | $12.41 |
| Indicator | WEAV | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 48.71 | 56.12 |
| Support Level | $6.24 | $7.33 |
| Resistance Level | $6.46 | $7.80 |
| Average True Range (ATR) | 0.22 | 0.38 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 78.74 | 81.58 |
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.